According to 3 recent double-blind placebo-controlled studies, low-dose orlistat (60 mg), coupled with a reduced-calorie diet, leads to significant weight loss and improved lipid and blood pressure profiles and is well tolerated.

Fasting plasma glucose may be the best predictor of risk of new-onset diabetes in hypertension patients, showing that the risk of new-onset diabetes was 19-fold higher than those in the lowest quartile according to a subgroup analysis of data from a major trial.

Participants who were compliant had a 38.2% reduced risk of developing diabetes.

Treating “postprandial hyperglycemia” — the spike in blood sugar that occur after meals — with the drug Precose (also known as acarbose) does not delay the progression of early type 2 diabetes, according to a study.

Watchful waiting when faced with overweight preschoolers and elementary school children is poor pediatric practice.

At the same time researchers from a British medical school laid claim to genetic research that could help to prevent the illness.

Australian research has proven the effectiveness of a steroid treatment for a type of diabetic blindness

Further analysis of patients who developed diabetes during the Anglo-Scandinavian Cardiac Outcomes Trial – Blood Pressure Lowering Arm (ASCOT-BPLA) has allowed investigators to create a risk score that appears to discriminate those at highest risk for development of new-onset diabetes (NOD) during antihypertensive therapy.

It is deplorable for a doctor to lecture a patient on taking more careful precautions against heart disease, while there is McDonald’s in the hospital’s lobby serving a fried-food lunch.”

A portable, automated device accurately detects electrophysiological abnormalities in the sural nerve, indicating diabetic sensorimotor polyneuropathy,